Snider Lindy 4
4 · Intiva BioPharma Inc. · Filed Jun 29, 2018
Insider Transaction Report
Form 4
Snider Lindy
Director
Transactions
- Exercise of In-Money
Class B Warrants (right to buy)
2018-06-19−40,000→ 0 totalExercise: $0.38From: 2017-11-29Exp: 2018-06-29→ Common Stock (40,000 underlying) - Exercise of In-Money
Common Stock
2018-06-19$0.38/sh+40,000$15,200→ 480,000 total
Holdings
- 40,000
Class C Warrants (right to buy)
Exercise: $0.50From: 2017-11-29Exp: 2018-07-27→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Acquired in exchange for all of Lindy Snider's Class B warrants of Intiva BioPharma Inc.